Core Viewpoint - AAC Technologies (02018) has seen a nearly 3% increase in stock price, currently at 38.8 HKD, with a trading volume of 35.08 million HKD, indicating positive market sentiment towards the company due to its advancements in the XR industry [1] Group 1: Company Developments - AAC Technologies has successfully transitioned its AR device for core customers in the North American market from the conceptual phase to mass production, marking a significant milestone in its operational capabilities [1] - The AR device meets key market demands for high-quality display and lightweight design, enhancing its compatibility in the AR smart glasses segment [1] Group 2: Industry Insights - The XR industry is shifting from a conceptual exploration phase to a structural growth phase, with North America identified as a major consumer region for XR technology [1] - According to CounterPoint Research, AR smart glasses sales in North America have increased by 68% year-on-year as of Q2 2025, highlighting a robust market for AAC Technologies' products [1] - The successful mass production and delivery of AAC Technologies' AR device signifies its entry into the core supply chain of North America's AR market [1]

天眼查资料显示，瑞声光电科技（常州）有限公司，成立于2006年，位于常州市，是一家以从事其他制 造业为主的企业。企业注册资本43780万美元。通过天眼查大数据分析，瑞声光电科技（常州）有限公 司共对外投资了1家企业，参与招投标项目39次，财产线索方面有商标信息4条，专利信息1541条，此外 企业还拥有行政许可33个。 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 本文源自：市场资讯 作者：情报员 国家知识产权局信息显示，瑞声光电科技（常州）有限公司取得一项名为"电路及发声器件"的专利，授 权公告号CN115396791B，申请日期为2022年8月。 ...

证券时报·数据宝统计，瑞声科技在港交所公告显示，12月23日以每股37.500港元至38.020港元的价格回 购15.00万股，回购金额达567.72万港元。该股当日收盘价37.920港元，下跌0.47%，全天成交额7920.06 万港元。 | 日期 | 回购股数（万股） | 回购最高价（港元） | 回购最低价（港元） | 回购金额（万港元） | | --- | --- | --- | --- | --- | | 2025.12.23 | 15.00 | 38.020 | 37.500 | 567.72 | | 2025.12.18 | 15.00 | 37.920 | 37.460 | 565.28 | | 2025.12.17 | 15.00 | 38.360 | 37.560 | 570.18 | | 2025.12.16 | 11.45 | 38.500 | 37.800 | 437.30 | | 2025.12.15 | 10.00 | 38.980 | 38.240 | 386.27 | | 2025.12.11 | 30.00 | 37.800 | 37.220 | 1129.64 | | 20 ...

Core Viewpoint - AAC Technologies (02018) announced a share buyback plan, investing HKD 5.6772 million to repurchase 150,000 shares at a price range of HKD 37.50 to 38.02 per share [1] Group 1 - The company will execute the buyback on December 23, 2025 [1] - The total investment for the buyback is approximately HKD 5.6772 million [1] - The repurchase price per share is set between HKD 37.50 and 38.02 [1]

智通财经APP讯，瑞声科技(02018)发布公告，于2025年12月23日该公司斥资567.72万港元回购15万股， 回购价格为每股37.50-38.02港元。 ...

格隆汇12月23日丨瑞声科技(02018.HK)发布公告，2025年12月23日耗资567.72万港元回购15万股，回购 价格每股37.5-38.02港元。 ...

如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02018 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | 於下列日期開始時的結存(註1) | 2025年12月18日 | 1,168,586,500 | | 2 ...

瑞声声学科技（深圳）有限公司，成立于2004年，位于深圳市，是一家以从事计算机、通信和其他电子 设备制造业为主的企业。企业注册资本14158万美元。通过天眼查大数据分析，瑞声声学科技（深圳） 有限公司共对外投资了12家企业，参与招投标项目60次，财产线索方面有商标信息2条，专利信息1278 条，此外企业还拥有行政许可90个。 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 本文源自：市场资讯 国家知识产权局信息显示，瑞声光电科技（常州）有限公司、瑞声声学科技（深圳）有限公司取得一项 名为"车内独立音区控制方法、系统及相关设备"的专利，授权公告号CN114390396B，申请日期为2021 年12月。 天眼查资料显示，瑞声光电科技（常州）有限公司，成立于2006年，位于常州市，是一家以从事其他制 造业为主的企业。企业注册资本43780万美元。通过天眼查大数据分析，瑞声光电科技（常州）有限公 司共对外投资了1家企业，参与招投标项目39次，财产线索方面有商标信息4条，专利信息1541条，此外 企业还拥有行政许可33个。 作者：情报员 ...

Core Viewpoint - GenSight Biologics has received compassionate use authorization from the French medicines safety agency ANSM for its innovative gene therapies targeting retinal neurodegenerative diseases and central nervous system disorders [1] Company Summary - GenSight Biologics is a biopharma company focused on developing and commercializing gene therapies [1] - The company is listed on Euronext under the ticker SIGHT and is eligible for PEA-PME [1] Regulatory Update - The French medicines safety agency ANSM has granted compassionate use authorization (Autorisation d'Accès Compassionnel, or AA) for GenSight's therapies [1]

Core Insights - The XR industry is transitioning from conceptual exploration to structural growth, with significant market activity and supply chain developments expected in the second half of 2025 [1] - AAC Technologies' acquisition of Dispelix positions it to leverage advanced optical technologies for AR products, aiming for mass production by 2026 [1] Group 1: Technological Advancements - Dispelix's etched waveguide technology represents a generational leap, addressing key AR challenges such as weight, image quality, and power consumption [3] - Dispelix products achieve a field of view (FOV) of 20°-70°, significantly outperforming traditional waveguide technologies [5] - The thickness of Dispelix's etched waveguide products ranges from 0.4 to 0.7mm, reducing size by over 60% compared to traditional options, while maintaining high optical performance [6] Group 2: Strategic Partnerships - AAC Technologies is collaborating with major tech players like Google and Meta to develop next-generation XR reference design platforms, enhancing its supply chain influence [7] - The integration of core components and system modules allows AAC Technologies to streamline production cycles and enhance product delivery [8] Group 3: Market Potential - The XR market is projected to see explosive growth, with AI glasses expected to reach 112 million units by 2030 and a market size of $40 billion, reflecting a compound annual growth rate of 112% [11] - AAC Technologies focuses on high-value components for AR glasses, with individual product values exceeding $300, which constitutes over 70% of the core hardware costs [11] - The company is well-positioned to become a leading player in the global XR supply chain, capitalizing on technological barriers and strategic partnerships [11]